BeStock  
Stocks › TGTX

TG Therapeutics TGTX

US equityMarket cap rank #1443
$63.34 −$1.54 (-2.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $63.21 -0.21%
Open$64.10
Prev close$64.88
Day range$63.12 – $65.64
Volume2.09M
Market cap$9.57B
P/E (TTM)94.5
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$259.94M+60.7% YoY
Operating profit$85.90M+192.5% YoY
Net profit$55.46M-85.8% YoY
Diluted EPS$0.35-85.6% YoY
Free cash flow$44.95M+293.5% YoY
Operating cash flow$45.23M

Revenue, last 8 quarters

$108.2MDec '24$120.9MMar '25$141.1MJun '25$161.7MSep '25$192.6MDec '25$204.9MMar '26$240.3MJun '26$259.9MSep '26

Net profit, last 8 quarters

$23.3MDec '24$5.1MMar '25$28.2MJun '25$390.9MSep '25$23.0MDec '25$19.8MMar '26$7.8MJun '26$55.5MSep '26

Diluted EPS by quarter

0.15Dec '240.03Mar '250.17Jun '252.43Sep '250.14Dec '250.12Mar '260.05Jun '260.35Sep '26

Free cash flow by quarter

$-25.7MDec '24$-28.7MMar '25$7.4MJun '25$-23.2MSep '25$19.6MDec '25$-17.9MMar '26$39.0MJun '26$44.9MSep '26

Annual revenue

$152.0KFY20$6.7MFY21$2.8MFY22$233.7MFY23$329.0MFY24$616.3MFY25

Profitability & balance sheet

Gross margin82.7%
Operating margin21.5%
Net margin11.8%
Return on equity18.0%
Return on assets8.1%
Return on invested capital12.7%
Current ratio4.50
Liabilities / assets64.1%
Cash & investments$504.67M
Total debt$752.53M
Net cash (debt)-$247.86M
Free cash flow / sales9.5%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $259.94M $240.34M $204.92M $616.29M $192.57M
Total Operating Revenue $259.94M $240.34M $204.92M $616.29M $192.57M
Cost of Revenue $42.08M $41.19M $33.51M $100.71M $38.14M
Gross Profit $217.86M $199.14M $171.41M $515.57M $154.43M
Operating Expense $131.96M $177.47M $136.61M $392.25M $103.94M
Selling and Admin Expenses $88.22M $90.20M $93.09M $248.65M $66.38M
-General & Admin Expense $88.22M $90.20M $93.09M $248.65M $66.38M
Research & Development $43.74M $87.27M $43.52M $143.60M $37.56M
Operating Profit $85.90M $21.67M $34.80M $123.32M $50.49M
Net Non-Operating Interest Income (Expense) -$15.82M -$16.57M -$7.67M -$26.73M -$6.53M
Non-Operating Interest Expense $15.82M $16.57M $7.67M $26.73M $6.53M
Other Income (Expense) $3.78M $5.13M -$6.77M $10.79M $1.13M
Special Income (Charges) $0.00 $0.00 -$9.15M – –
Other Non-Operating Income (Expenses) $3.78M $5.13M $2.39M $10.79M $1.13M
Pretax Profit $73.86M $10.23M $20.36M $107.39M $45.09M
Tax $18.40M $2.45M $586,000.00 -$339.79M $22.06M
Net Profit $55.46M $7.78M $19.78M $447.18M $23.04M
Profit from Continuing Operations $55.46M $7.78M $19.78M $447.18M $23.04M
Net Income to Parent Company $55.46M $7.78M $19.78M $447.18M $23.04M
Net Income to Common Stockholders $55.46M $7.78M $19.78M $447.18M $23.04M
Basic EPS $0.39 $0.05 $0.14 $3.10 $0.16
Diluted EPS $0.35 $0.05 $0.12 $2.77 $0.14
-Less:Other Special Charges – – $9.15M – –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.59B $1.64B $1.53B $1.06B $1.06B
Total Current Assets $1.17B $1.15B $1.09B $630.76M $630.76M
Cash and Cash Equivalents & Short-Term Investments $504.67M $552.25M $514.43M $141.97M $141.97M
-Cash and Cash Equivalents $429.38M $482.58M $442.21M $79.15M $79.15M
-Short Term Investments $75.30M $69.67M $72.22M $62.82M $62.82M
Receivables $416.82M $401.57M $392.05M $305.63M $305.63M
-Accounts Receivable $416.82M $401.57M $392.05M $305.63M $305.63M
Inventory $194.32M $147.97M $129.03M $125.59M $125.59M
Other Current Assets $55.64M $43.90M $51.46M $57.58M $57.58M
Total Non-Current Assets $420.81M $493.94M $441.87M $432.49M $432.49M
Net PPE $6.83M $7.09M $6.48M $6.28M $6.28M
-Gross PPE $6.83M $7.09M $6.48M $6.28M $6.28M
Investments and Advances $56.04M $64.37M $87.88M $74.83M $74.83M
-Available for Sale Securities $4.00M – – – –
-Held to Maturity Securities $52.04M $64.37M $61.54M $59.14M $59.14M
Non-Current Deferred Assets $333.38M $343.43M $344.14M $348.00M $348.00M
Other Non-Current Assets $24.56M $79.06M $3.37M $3.39M $3.39M
Total Liabilities $1.02B $1.04B $945.71M $415.23M $415.23M
Total Current Liabilities $260.53M $268.49M $187.11M $153.76M $153.76M
Short-Term Debt and Capital Lease Obligation $1.84M $1.91M $1.82M $1.04M $1.04M
-Current Capital Lease Obligation $1.84M $1.91M $1.82M $1.04M $1.04M
Current Deferred Liabilities $26.10M $16.83M $17.19M $21.23M $21.23M
Other Current Liabilities $1.22M $857,000.00 $596,000.00 $2.12M $2.12M
Total Non-Current Liabilities $759.60M $767.05M $758.60M $261.47M $261.47M
Long Term Debt and Capital Lease Obligation $752.53M $752.53M $751.74M $252.67M $252.67M
-Long Term Debt $745.63M $745.39M $745.14M $245.65M $245.65M
-Long Term Capital Lease Obligation $6.90M $7.14M $6.60M $7.02M $7.02M
Non-Current Deferred Liabilities $7.07M $14.53M $6.86M $8.81M $8.81M
Total Equity $572.13M $604.08M $583.13M $648.02M $648.02M
Stockholders' Equity $572.13M $604.08M $583.13M $648.02M $648.02M
Capital Stock $160,000.00 $160,000.00 $160,000.00 $159,000.00 $159,000.00
-Common Stock $160,000.00 $160,000.00 $160,000.00 $159,000.00 $159,000.00
Additional Paid-In Capital $1.87B $1.86B $1.85B $1.83B $1.83B
Retained Earnings -$998.99M -$1.05B -$1.06B -$1.08B -$1.08B
Less: Treasury Stock -$300.22M -$200.23M -$200.23M -$100.23M -$100.23M
-Long Term Equity Investment – – $26.35M $15.69M $15.69M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $45.23M $39.26M -$17.89M -$24.77M $19.66M
Net cash flow from continuing operations $45.23M $39.26M -$17.89M -$24.77M $19.66M
Net Income from Continuing Operations $55.46M $7.78M $19.78M $447.18M $23.04M
Gain/Loss from Continuing Operations $0.00 $0.00 $9.15M – –
Depreciation & Depletion & Amortization $119,000.00 $96,000.00 $80,000.00 $244,000.00 $67,000.00
Deferred Tax $10.05M $708,000.00 $3.86M -$348.00M $18.63M
Other Non-Cash Items $728,000.00 $1.21M $946,000.00 $2.99M $600,000.00
Change in Working Capital -$46.99M $3.07M -$69.76M -$194.54M -$44.54M
-Change in Receivables -$15.26M -$9.52M -$86.42M -$176.44M -$40.24M
-Change in Inventory $9.50M -$66.82M -$13.28M -$33.45M $563,000.00
-Change in Payables and Accrued Expense -$28.60M $59.21M $27.30M $55.88M $2.01M
-Change in Other Current Assets -$14.27M $13.57M $10.66M -$42.43M -$1.91M
-Change in Other Current Liabilities -$179,000.00 -$670,000.00 -$2.04M -$4.48M -$253,000.00
-Change In Other Working Capital $1.82M $7.30M -$5.99M $6.39M -$4.71M
Net cash flow from investing $1.33M $1.03M -$9.86M $13.80M -$15.64M
Net Cash Flow from Continuing Investing Activities $1.33M $1.03M -$9.86M $13.80M -$15.64M
Net PPE Purchase and Sale -$282,000.00 -$293,000.00 -$51,000.00 -$214,000.00 -$67,000.00
Net Investment Purchase and Sale $2.61M $1.32M -$9.81M $14.01M -$16.82M
Financing Cash Flow -$99.75M $85,000.00 $390.83M -$89.73M $1.06M
Net Cash Flow from Continuing Financing Activities -$99.75M $85,000.00 $390.83M -$89.73M $1.06M
Net Issuance Payments Of Debt $0.00 $0.00 $492.66M $0.00 $0.00
Net Common Stock Issuance -$100.00M $0.00 -$99.99M -$91.24M $0.00
Cash Dividends Paid $0.00 $0.00 $0.00 – –
Proceeds from Stock Option Exercised $253,000.00 $85,000.00 $763,000.00 $1.51M $1.06M
Ending Cash Balance $430.75M $483.94M $443.56M $80.49M $80.49M
Net Change in Cash -$53.19M $40.38M $363.07M -$100.70M $5.08M
Beginning Cash Balance $483.94M $443.56M $80.49M $181.19M $75.41M
Free Cash Flow $44.95M $38.97M -$17.95M -$24.99M $19.59M

Discussion

No comments yet — be the first to weigh in on TGTX.

Sign in to join the discussion.

Scroll to Top